2002 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Please Choose a Presenter
» Richard J. Duma, M.D., Ph.D.
» Scott P. Layne, M.D.
» Stuart B. Levy, M.D.
» Lance E. Rodewald, M.D.
» Robert A. Whitney, D.V.M.
Richard J. Duma, M.D., Ph.D.
Director
Division of Infectious Diseases
Halifax Medical Center
Daytona Beach, Florida
Dr. Duma is director of the Division of Infectious Diseases at Halifax Medical Center in Daytona Beach, FL, and clinical professor of medicine at the Medical College of Virginia (MCV). He is also a trustee and one of the founders of the National Foundation for Infectious Diseases (NFID), a nonprofit, public foundation established in 1973, to support research and education into the causes, cures and prevention of infectious diseases. Dr. Duma, known internationally in the field of infectious diseases, was elected vice president of the NFID Board of Directors from 1973 to 1975 and president from 1975 to 1991. He served as its executive director from 1991 to 1995.
Prior to becoming executive director of NFID, Dr. Duma was a tenured professor of medicine, pathology and microbiology and chairman, Division of Infectious Diseases, MCV. He was also director of hospital epidemiology and chairman of the MCV Hospital Infection Control Committee.
Dr. Duma has served as chairman of the Steering Committee for the National Coalition for Adult Immunization, which is a national network of more than 120 health care organizations dedicated to promoting adult immunization, primarily through educational and motivational activities. He was also the first chairman of the U.S. Pharmacopeia National Coordinating Committee on Large Volume Parenterals, which played a major role in setting standards and ensuring the safety of the nation's intravenous fluids and medicinals. He is also a long standing member of the Data Monitoring Safety Board for the Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. As the author of more than 100 scientific articles and research studies, he has written more than 30 chapters and is a reviewer for numerous medical journals.
Dr. Duma received his medical degree from the University of Virginia Medical School and his doctorate in experimental pathology and microbiology from Virginia Commonwealth University. He is board-certified in internal medicine and infectious diseases and is a fellow of both the American College of Physicians and the Infectious Diseases Society of America, as well as a member of numerous other professional societies. He is a past president of the Infectious Diseases Society of Florida.
Return to the list of presenters.
Scott P. Layne, M.D.
Associate Professor
School of Public Health
University of California, Los Angeles
Los Angeles, California
Dr. Scott P. Layne is a tenured associate professor of epidemiology at the UCLA School of Public Health. Before joining UCLA in 1994, he was a staff member at the Los Alamos and Lawrence Livermore National Laboratories.
Layne is known for multidisciplinary work that spans biology, medicine, and physics. He is a board certified physician in internal medicine and infectious diseases and trained in applied physics. He has authored over 40 publications and patents and is editor of the book Firepower in the Lab: Automation in the Fight Against Infectious Diseasesand Bioterrorism published by the Joseph Henry Press in 2001. Layne is also an editor of Jane's Chem-Bio Handbook, second edition.
In 1988, Layne organized a workshop for the White House's Office of Science and Technology Policy titled A National Effort to Model AIDS Epidemiology, which produced a report that shaped research efforts in the United States. Around the same time, his numerical research on AIDS used a combination of computer models and epidemiologic data to understand and predict the spread of infection in the United States. His basic scientific research on HIV used a combination of mathematical models and laboratory experiments to understand the kinetics of infection and examine how immunoglobulins and drugs block viral attachment and infection.
In 1999, Layne organized a meeting under the auspices of the Institute of Medicine and National Academy of Engineering titled Automation in Threat Reduction and Infectious Disease Research: Needs and New Directions. The agenda focused on the challenges posed by infectious diseases, food safety, and biological terrorism and also on the solutions offered by available scientific knowledge and technologic capabilities. What emerged was a plan to build new kinds of high-speed laboratory and database resources that expedite disease surveillance and intervention efforts on a global scale. The events of September 11th reinforce the need for such high-powered resources.
Layne teaches graduate level courses at UCLA on infectious diseases, terrorism and mass destruction, and public health responses to bioterrorism. He is also an instructor on bioterrorism preparation and response for the U.S. Department of Justice and lectures around the country in this capacity.
Return to the list of presenters.
Stuart B. Levy, M.D.
Stuart B. Levy, M.D., Professor of Medicine and of Molecular Biology and Microbiology, is the Director of the Center for Adaptation Genetics and Drug Resistance at Tufts University School of Medicine and Staff Physician at the New England Medical Center. He also serves as President of the Alliance for the Prudent Use of Antibiotics, an international organization with members in over 100 countries of the world. He is the past President of the 42,000 member American Society for Microbiology. He is co-founder and Chief Scientific Officer of Paratek Pharmaceuticals, Inc.
Levy is well known for his contributions to the antibiotic resistance field. He has published over 250 papers on antibiotic use and resistance, and has edited four books and two special journal editions devoted to the subject. His 1992 book, The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle, has been cited widely in both the lay and scientific media. It presents the conflicting consequences of antibiotic use -- curing disease and selecting resistant bacteria. A new updated edition of his book was released in January 2002 by Perseus Books.
Levy led the discovery of the first characterized energy-dependent antibiotic efflux mechanism and efflux protein, that for tetracycline resistance. He has written extensively about efflux as a mechanism for drug resistance. His accomplishments include the discovery of a regulatory locus mar for intrinsic multiple antibiotic resistance/susceptibility among the Enterobacteriaceae and demonstration of transfer of resistance among animals and people.
Levy is a Fellow of the American College of Physicians, Infectious Disease Society of America, and the American Academy of Microbiology. He has organized and chaired four international meetings on drug resistance and was Chairperson of the U.S. Fogarty Center three-year international study of "Antibiotic use and resistance worldwide". He has been, and continues to be, a consultant to international and national organizations and agencies, including the World Health Organization in Geneva and Southeast Asia, the U.S. FDA and U.S. EPA. He was awarded the 1995 Hoechst-Roussel Award for esteemed research in antimicrobial chemotherapy by the American Society for Microbiology. He was awarded an honorary degree in biology from Wesleyan University in 1998 and from Des Moines University in 2001.
Dr. Levy has been featured and quoted for his work on antibiotic use and resistance in major national and international newspapers and magazines including Time, Newsweek, U.S. News and World Report, The New Yorker, The New York Times, The Washington Post, USA Today. He has appeared on Good Morning America, Nova, The Today Show, ABC Prime Time, CBS 48 Hours, the Jim Lehrer News Hour, and CNN. More recently, he appeared on CBS Evening News, ABC World News Tonight and the NBC Today shows and on many National Public Radio programs including Fresh Air, The Connection, Science Friday, and All Things Considered.
Return to the list of presenters.
Lance E. Rodewald, M.D.
Director, Immunization Services Division
National Immunization Program
Centers for Disease Control and Prevention
Atlanta, Georgia
Dr. Rodewald is director of the Immunization Services Division in the National Immunization Program of the Centers for Disease Control and Prevention. This division administers the Vaccines for Children program and a grants program to state and urban area health departments; conducts health services research; and provides training and education to health professionals. He received his medical degree from Southern Illinois University School of Medicine and trained in pediatrics at the University of Virginia and the Robert Wood Johnson School of Medicine and Dentistry. He had fellowship training in medical informatics at the University of Illinois, and health services research training at the University of Rochester School of Medicine and Dentistry.
At the University of Rochester he was associate professor of pediatrics and emergency medicine. He joined the Centers for Disease Control and Prevention in 1996 as associate director for science in the Immunization Services Division. His research interests include the structure of the immunization delivery system, methods to improve immunization coverage levels, and methods to integrate more completely and seamlessly immunizations into primary care.
Return to the list of presenters.
Robert A. Whitney, D.V.M.
President
EARTHSPAN
Steilacoom, WA
Dr. Whitney is former Deputy Surgeon General, United States Public Health Service. He is the president of EARTHSPAN, a not-for-profit institute dedicated to environmental health, natural resource conservation, biodiversity and ecosystem preservation.
Dr. Whitney¼s public service career began as a veterinary officer in the U.S. Army Veterinary Corps from 1959-1971. He served as director of the U.S. Army Veterinary Corps Training Program in Laboratory Animal Medicine at Edgewood Arsenal in Maryland from 1965-1970. He also served one year in South Vietnam at the Rabies Diagnostic Laboratory in Da Nang. In 1971 he entered the Commissioned Corps of the U.S. Public Health Service with duty station at the National Institutes of Health in Bethesda, Maryland. He served in numerous positions at NIH, including Founding Director of the National Center for Research Resources.
While at NIH, he served from 1985-1989 as Chief Veterinary Officer for the U.S. Public Health Service. From 1992-1994 he served as Deputy Surgeon General of the U.S. Public Health Service. In 1993, he was appointed Acting Surgeon General of the United States.
In 1994 he retired from federal service and became president of EARTHSPAN. EARTHSPAN uses satellite technology to track birds and other species, and to identify critical habitats and environmental conditions around the world.
He has been recognized many times for his public service, including the American Veterinary Medical Association Animal Welfare Award in 1994 and the Surgeon General's Medallion in 1993. He has received numerous medals for meritorious service to the U.S. Public Health Service. In 2000 he was named to the Oklahoma State University Hall of Fame, and has been named a Distinguished Alumnus at the Ohio State University, where he received his master's degree in pharmacology.
He is the author of the Laboratory Primate Handbook, as well as more than 40 scientific publications. He is a past president of the American College of Laboratory Animal Medicine and the American Association for Laboratory Animal Science.
Dr. Whitney serves on the board, or is a consultant for numerous health-related organizations, including the National Foundation for Infectious Diseases, the American Veterinary Epidemiology Society, the Scientists' Center for Animal Welfare, the Pan American Health Organization and the NASA Bion Project.